Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?

To: ahhaha who wrote (1060)	9/23/1998 1:15:00 AM
From: jake burns	Read Replies (1) \| Respond to of 1510

Random thoughts: This board is dead, but Yahoo! is alive and well. Ahhaha: Always interested to learn from you. You mentioned that the stock was sensitive to marginal buying, but not sensitive to marginal supply. What is your guess as to why this occurred? Is this a harbinger of a possible short squeeze? The last 5 years have not been great for imnr shareholders, but I believe the next 3 will be, as Remune and RA will come to market, and the gene therapy platform will generate revenues as well. And by that time, we'll have a clearer picture of the cancer drugs.